Lars Ekman
CIK 1376117 · last filed 2026-05-15
Lars Ekman is a corporate insider who has filed 71 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for PRTA, was dated May 15, 2026. Across all open-market trades the lifetime net is −$15.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $458.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$458.1K
6
71
-$15.03M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PRTA | Director | 3,148 | $8.25 | $26.0K | -$7.55M | 20 | 2026-05-15 |
| AMRN | Director | 0 | $15.24 | $0 | -$7.47M | 17 | 2022-06-29 |
| RARE | Director | 17,745 | $24.35 | $432.1K | $0 | 8 | 2022-06-28 |
| Spark Therapeutics, Inc. (ONCE) Delisted | Director | 0 | — | — | $0 | 5 | 2019-12-17 |
| SOPHIRIS BIO INC. (SPHS) Delisted | Director | 520 | — | — | -$4.5K | 7 | 2019-06-28 |
| ARYx Therapeutics, Inc. (ARYX) Delisted | Director | — | — | — | $0 | 3 | 2010-05-03 |
Recent Filings
71 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-15 | PRTA | Grant (A) | — | $0 | EDGAR |
| 2025-05-16 | PRTA | Grant (A) | — | $0 | EDGAR |
| 2024-05-17 | PRTA | Grant (A) | — | $0 | EDGAR |
| 2023-05-19 | PRTA | Grant (A) | — | $0 | EDGAR |
| 2023-01-05 | PRTA | Mixed | — | -$784.9K | EDGAR |
| 2022-12-02 | PRTA | Mixed | — | -$873.9K | EDGAR |
| 2022-11-03 | PRTA | Mixed | — | -$894.2K | EDGAR |
| 2022-10-05 | PRTA | Mixed | — | -$872.6K | EDGAR |
| 2022-09-30 | PRTA | Mixed | — | -$1.32M | EDGAR |
| 2022-06-29 | AMRN | Grant (A) | — | $0 | EDGAR |